Sign up for a study to help others like you.

The WAKIX Pregnancy Registry is a study that collects information from women who take medicines like WAKIX while pregnant as well as from those who don’t.

It tracks the health of their babies up to age one. There are no additional visits or tests. You just give the researchers permission to collect health information from your doctors about you and your baby, up to age one.

Would you like to participate?
Contact the registry today.

Register
Image of pregnant woman

Why is it important?

Your participation could help other pregnant women and healthcare professionals learn more about the safety of WAKIX when used during pregnancy.

Who is eligible to enroll?

The WAKIX Pregnancy Registry is open to pregnant women of any age who provide consent to participate and meet certain enrollment criteria. You may be eligible to participate even if you are not taking WAKIX.

Please note, this registry is for US patients only.

Compensation for participation?

You may receive $50.00 for your participation in the registry.

Talk to your healthcare provider

We encourage you to talk to your doctor if you are pregnant, nursing, or plan to become pregnant while taking WAKIX.

Enrollment icon

How do I enroll?

If you are interested in enrolling, please contact the Registry team by email, phone (toll-free between 8:30am - 5:00pm EST Monday-Friday) or filling in our online form.

Email:

Phone:
1-877-302-2813 toll-free between 8:30am - 5:00pm EST Monday-Friday.

Contact form

Indications and Usage

WAKIX is a prescription medicine used to treat:

  • excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy.
  • excessive daytime sleepiness (EDS) in children 6 years of age and older with narcolepsy

Important Safety Information

Do not take WAKIX if you are allergic to pitolisant or any ingredient in WAKIX, or if you have severe liver disease.

WAKIX can cause a change in the electrical activity of the heart known as QT prolongation. This is a heart rhythm problem that can lead to an abnormal heartbeat. You have a higher chance of getting QT prolongation if you have certain heart or other medical conditions, or if you take WAKIX with certain medicines. Tell your healthcare provider right away if you have a change in your heartbeat or if you feel dizzy or faint while taking WAKIX.

Tell your healthcare provider about all your medical conditions, including if you have any heart, liver, or kidney problems, or problems with blood levels of your electrolytes, such as potassium or magnesium.

Tell your healthcare provider about all the medicines you take or plan to take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking WAKIX with certain medicines may cause side effects or affect the way each other works.

Hormonal birth control methods may not work while taking WAKIX. Use an alternative non-hormonal birth control method during treatment with WAKIX and for at least 21 days after stopping WAKIX.

Tell your healthcare provider if you are pregnant or planning to become pregnant. You are encouraged to enroll in the WAKIX pregnancy registry if you become pregnant while taking WAKIX. The registry collects information about the health of you and your baby. To enroll or obtain information from the registry, call 1-800-833-7460.

The most common side effects of WAKIX in adults include insomnia, nausea, and anxiety.

The most common side effects of WAKIX in children include headache and insomnia.

These are not all the possible side effects of WAKIX. Call your healthcare provider for medical advice about side effects.

It is not known if WAKIX is safe and effective to treat excessive daytime sleepiness in children under 6 years of age with narcolepsy or to treat cataplexy in people under 18 years of age with narcolepsy.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You can also report negative side effects to Harmony Biosciences at 1-800-833-7460.

Please see accompanying Full Prescribing Information.